Bruker Daltonics

In this interview, Technology Networks spoke to Heiko Neuweger, director of Bioinformatics Life Science Mass Spectrometry Software R&D at Bruker, to learn about the importance of target compound annotation and identification, the advantages of integrating collision cross section (CCS) information into workflows and the benefits of CCS-Predict Pro.

QC can be performed after data acquisition, but unexpected deviations can waste valuable time and resources. Instead, real-time QC allows for active monitoring of data quality as the analysis is being performed, preventing errors that can compromise the analysis.

This poster highlights the latest spatial biology solutions for GBM tissue analysis, offering critical insights into the metabolic signatures and immune cell infiltration of this tissue type.

This eBook explores how recent advances in trapped ion mobility spectrometry (TIMS) have revolutionized TPD for a faster, more accurate development processes.

In this webinar, our expert speaker will introduce a novel workflow based on trapped ion mobility spectrometry (TIMS) for automated PFAS screening and identification against comprehensive suspect lists of almost 5,000 entries from the Norman network and NIST.

Oligonucleotides play a crucial role in modern drug development, therefore their accurate characterization is essential. However, given the sheer complexity and diversity of the types of oligonucleotides that are in clinical development, a range of diverse analytical approaches are necessary.

In this webinar, Dr. Balunas will showcase her latest research into deriving natural products from the marine invertebrate Botryllus schlosseri.

Crown Bioscience offers next generation ion mobility-mass spectrometry (IM-MS)-based-proteomics services to global clients.

This will allow clients to assess the biological function of proteins for understanding signaling mechanisms within cells as well as specific biomarkers to diseases, and systematically assess quantitative differences in protein profiles of distinct samples for biomedical and clinical research.

Hear how the capabilities of mass spectrometry (MS)-based proteomics are proving themselves in drug development and discovery and what this means for those working in oncology.

Bile acids are well known for their roles in cholesterol homeostasis, lipid absorption and as metabolic signaling molecules. They are implicated in a variety of disease states and therefore serve as an exciting focus on research in novel biomarker discovery.